Literature DB >> 10843383

Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction.

V Vezys1, S Olson, L Lefrançois.   

Abstract

Reactivity to intestinal epithelium-specific antigen was studied by transgenic expression of cytosolic ovalbumin controlled by an enterocyte-specific promoter. Transferred OVA-specific CD8 cells (OT-I) preferentially expanded in mucosal lymphoid tissues and the epithelium but failed to cause tissue damage. In contrast, concomitant VSV-ova infection induced OT-I-mediated epithelial cell destruction that correlated with antigen density. OT-I cells retained in the epithelium exhibited high levels of lytic activity but were unable to produce cytokines. The mice were systemically tolerant to OVA since endogenous CD8 cells were nonresponsive to VSV-ova infection. Thus, intestinal antigen gained access to peripheral tissues via absorption from effete epithelial cells. This system demonstrated a requirement for inflammation to drive pathogenic autoreactivity against enterocytes and identified pathways of intestine-specific immunoregulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843383     DOI: 10.1016/s1074-7613(00)80202-2

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  52 in total

Review 1.  Once a killer, always a killer: from cytotoxic T cell to memory cell.

Authors:  Leo Lefrançois; Joshua J Obar
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration.

Authors:  Isabel Correa; Tim Plunkett; Anda Vlad; Arron Mungul; Jessica Candelora-Kettel; Joy M Burchell; Joyce Taylor-Papadimitriou; Olivera J Finn
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

Review 3.  The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs.

Authors:  Shannon J Turley; Anne L Fletcher; Kutlu G Elpek
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

4.  CD70+ antigen-presenting cells control the proliferation and differentiation of T cells in the intestinal mucosa.

Authors:  Amale Laouar; Viraga Haridas; Dorothy Vargas; Xia Zhinan; David Chaplin; Rene A W van Lier; N Manjunath
Journal:  Nat Immunol       Date:  2005-06-05       Impact factor: 25.606

Review 5.  Fibroblastic reticular cells: organization and regulation of the T lymphocyte life cycle.

Authors:  Flavian D Brown; Shannon J Turley
Journal:  J Immunol       Date:  2015-02-15       Impact factor: 5.422

6.  Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cells.

Authors:  Adam T Hagymasi; Aaron M Slaiby; Marianne A Mihalyo; Harry Z Qui; David J Zammit; Leo Lefrancois; Adam J Adler
Journal:  J Immunol       Date:  2007-08-01       Impact factor: 5.422

7.  Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection.

Authors:  Joshua J Obar; Kamal M Khanna; Leo Lefrançois
Journal:  Immunity       Date:  2008-05-22       Impact factor: 31.745

8.  Enhanced CD8 T cell cross-presentation by macrophages with targeted disruption of STAT3.

Authors:  Jason Brayer; Fengdong Cheng; Hongwei Wang; Pedro Horna; Ildefonso Vicente-Suarez; Javier Pinilla-Ibarz; Eduardo M Sotomayor
Journal:  Immunol Lett       Date:  2010-03-25       Impact factor: 3.685

9.  A 3-D enteroid-based model to study T-cell and epithelial cell interaction.

Authors:  Aneta Rogoz; Bernardo S Reis; Roos A Karssemeijer; Daniel Mucida
Journal:  J Immunol Methods       Date:  2015-04-02       Impact factor: 2.303

10.  Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockade.

Authors:  Kristen E Pauken; Christine E Nelson; Tijana Martinov; Vaiva Vezys; Brian T Fife; Justin A Spanier; James R Heffernan; Nathanael L Sahli; Clare F Quarnstrom; Kevin C Osum; Jason M Schenkel; Marc K Jenkins; Bruce R Blazar
Journal:  J Immunol       Date:  2015-03-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.